speb/financial-data huggingface dataset:
UUUU balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 36090000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Current Provisions: 3271000.00
UUUU cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1428000.00
UUUU income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 241554000.00
UUUU income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.04
UUUU income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -10844000.00
UUUU income_statement (quarterly, 2026-03-31) — EBIT: -14545000.00
UUUU income_statement (quarterly, 2026-03-31) — EBITDA: -13117000.00
UUUU income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -62000.00
UUUU cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 62000.00
UUUU cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 983000.00
UUUU cash_flow (quarterly, 2026-03-31) — End Cash Position: 131102000.00
UUUU cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 49689000.00
UUUU cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -3493000.00
UUUU cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -1137000.00
UUUU income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 292000.00
UUUU income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 4055000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -527000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 4320000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Gross PPE: 447257000.00
UUUU income_statement (quarterly, 2026-03-31) — Gross Profit: 14363000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 10481000.00
UUUU cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 48000.00
UUUU income_statement (quarterly, 2026-03-31) — Interest Income: 1731000.00
UUUU income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1731000.00
UUUU cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 32000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Interest Payable: 2609000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Inventory: 69034000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1399955000.00
UUUU cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -15097000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 10481000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 41268000.00
UUUU cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 52767000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 7416000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 676688000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 676688000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 17764000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 73976000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Minority Interest: 4049000.00
UUUU income_statement (quarterly, 2026-03-31) — Minority Interests: 116000.00
UUUU cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 52767000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Net Debt: 568242000.00
UUUU cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 782000.00
UUUU income_statement (quarterly, 2026-03-31) — Net Income: -10844000.00
UUUU income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -10844000.00
UUUU income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -10960000.00
UUUU income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -10844000.00
UUUU income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -10844000.00
UUUU cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -10960000.00
UUUU income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -10960000.00
UUUU income_statement (quarterly, 2026-03-31) — Net Interest Income: 1731000.00
UUUU cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -3573000.00
UUUU income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1731000.00
UUUU cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -5179000.00
UUUU cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 292000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Net PPE: 391410000.24
UUUU cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -11816000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 718947000.00
UUUU income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -15081000.00
UUUU income_statement (quarterly, 2026-03-31) — Normalized Income: -12022400.00
UUUU cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 8323000.00
UUUU cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -585000.00
UUUU income_statement (quarterly, 2026-03-31) — Operating Income: -14545000.00
UUUU income_statement (quarterly, 2026-03-31) — Operating Revenue: 35838000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 244410000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 5409000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 5428000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -527000.00
UUUU income_statement (quarterly, 2026-03-31) — Other Income Expense: 1902000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4320000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Investments: 30787000.00
UUUU cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -171000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 28941000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 805000.00
UUUU income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 12363000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Receivables: 77000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 802239000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Payables: 10365000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 27391000.00
UUUU income_statement (quarterly, 2026-03-31) — Pretax Income: -10912000.00
UUUU cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 2101000.00
UUUU cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -136113000.00
UUUU cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -11816000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Raw Materials: 20511000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Receivables: 7596000.00
UUUU income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 21475000.00
UUUU income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1428000.00
UUUU income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 2383000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -500501000.00
UUUU cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 132540000.00
UUUU income_statement (quarterly, 2026-03-31) — Selling General And Administration: 16545000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Share Issued: 244410000.00
UUUU income_statement (quarterly, 2026-03-31) — Special Income Charges: -2091000.00
UUUU cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3512000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 723267000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 718947000.00
UUUU income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 785600.00
UUUU income_statement (quarterly, 2026-03-31) — Tax Provision: 48000.00
UUUU income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
UUUU balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 2037000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Total Assets: 1458663000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1399955000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Total Debt: 676688000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 727316000.00
UUUU income_statement (quarterly, 2026-03-31) — Total Expenses: 50383000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 731347000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 465939000.24
UUUU balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 695257000.00
UUUU income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -16928000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 376000.00
UUUU income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1964000.00
UUUU income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1964000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Work In Process: 48523000.00
UUUU balance_sheet (quarterly, 2026-03-31) — Working Capital: 956634000.00
UVE cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 463000.00
UVE balance_sheet (annual, 2021-12-31) — Current Debt: 26759000.00
UVE balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 26759000.00
UVE cash_flow (annual, 2021-12-31) — Issuance Of Debt: 100000000.00
UVE cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 100000000.00
UVE cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 9296000.00
UVE balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 26759000.00
UVE balance_sheet (annual, 2021-12-31) — Preferred Shares Number: 10000.00
UVE cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 0.00
UVE cash_flow (annual, 2021-12-31) — Sale Of Investment Properties: 2591000.00
UVE balance_sheet (annual, 2021-12-31) — Taxes Receivable: 16947000.00
UVE income_statement (annual, 2022-12-31) — +Total Revenue: 1222658000.00
UVE balance_sheet (annual, 2022-12-31) — Accounts Payable: 384504000.00
UVE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 878424000.00
UVE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 112509000.00
UVE cash_flow (annual, 2022-12-31) — Amortization Of Securities: 8125000.00
UVE income_statement (annual, 2022-12-31) — Basic Average Shares: 30751000.00
UVE income_statement (annual, 2022-12-31) — Basic EPS: -0.72
UVE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 253143000.00
UVE cash_flow (annual, 2022-12-31) — Capital Expenditure: -4899000.00
UVE balance_sheet (annual, 2022-12-31) — Capital Stock: 472000.00
UVE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 388706000.00
UVE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1403332000.00
UVE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -23784000.00
UVE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -37456000.00
UVE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -148861000.00
UVE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 324515000.00
UVE cash_flow (annual, 2022-12-31) — Change In Account Payable: 195842000.00
UVE cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 0.00
UVE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -853000.00
UVE cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 31272000.00
UVE cash_flow (annual, 2022-12-31) — Change In Payable: 192068000.00
UVE cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 192068000.00
UVE cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -41434000.00
UVE cash_flow (annual, 2022-12-31) — Change In Receivables: -613422000.00
UVE cash_flow (annual, 2022-12-31) — Change In Tax Payable: 0.00
UVE cash_flow (annual, 2022-12-31) — Change In Working Capital: 350669000.00
UVE cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -628619000.00
UVE cash_flow (annual, 2022-12-31) — Changes In Cash: 138198000.00
UVE balance_sheet (annual, 2022-12-31) — Common Stock: 472000.00
UVE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -23774000.00
UVE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 287896000.00
UVE cash_flow (annual, 2022-12-31) — Common Stock Payments: -11643000.00
UVE balance_sheet (annual, 2022-12-31) — Current Debt: 0.00
UVE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 0.00
UVE cash_flow (annual, 2022-12-31) — Deferred Income Tax: -12126000.00
UVE cash_flow (annual, 2022-12-31) — Deferred Tax: -12126000.00
UVE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 7296000.00
UVE income_statement (annual, 2022-12-31) — Diluted Average Shares: 30751000.00
UVE income_statement (annual, 2022-12-31) — Diluted EPS: -0.72
UVE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -22267000.00
UVE income_statement (annual, 2022-12-31) — EBIT: -21341000.00
UVE cash_flow (annual, 2022-12-31) — End Cash Position: 391341000.00
UVE cash_flow (annual, 2022-12-31) — Excess Tax Benefit From Stock Based Compensation: 222000.00
UVE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -37456000.00
UVE cash_flow (annual, 2022-12-31) — Free Cash Flow: 319616000.00
UVE cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 83000.00
UVE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -21000.00
UVE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -103782000.00
UVE income_statement (annual, 2022-12-31) — General And Administrative Expense: 90638000.00
UVE cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 4202000.00
UVE balance_sheet (annual, 2022-12-31) — Income Tax Payable: 0.00
UVE income_statement (annual, 2022-12-31) — Interest Expense: 5906000.00
UVE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 5906000.00
UVE cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 5797000.00
UVE balance_sheet (annual, 2022-12-31) — Invested Capital: 390665000.00
UVE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -148861000.00
UVE balance_sheet (annual, 2022-12-31) — Investments And Advances: 1100095000.00
UVE balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 0.00
UVE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
UVE balance_sheet (annual, 2022-12-31) — Long Term Debt: 102769000.00
UVE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 102769000.00
UVE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
UVE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1471000.00
UVE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
UVE income_statement (annual, 2022-12-31) — Loss Adjustment Expense: 938399000.00
UVE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -11643000.00
UVE income_statement (annual, 2022-12-31) — Net Income: -22257000.00
UVE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -22267000.00
UVE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -22257000.00
UVE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -22257000.00
UVE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -22257000.00
UVE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -22257000.00
UVE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -22257000.00
UVE income_statement (annual, 2022-12-31) — Net Interest Income: -6609000.00
UVE cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -6000.00
UVE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -144053000.00
UVE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1471000.00
UVE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1471000.00
UVE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -6609000.00
UVE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -558000.00
UVE balance_sheet (annual, 2022-12-31) — Net PPE: 51404000.00
UVE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4802000.00
UVE income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: 938399000.00
UVE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 287896000.00
UVE income_statement (annual, 2022-12-31) — Normalized Income: -22257000.00
UVE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 324515000.00
UVE cash_flow (annual, 2022-12-31) — Operating Gains Losses: 62000.00
UVE income_statement (annual, 2022-12-31) — Operating Revenue: 1222658000.00
UVE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 30389000.00
UVE balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 0.00
UVE balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -103782000.00
UVE income_statement (annual, 2022-12-31) — Other Gand A: 90638000.00
UVE income_statement (annual, 2022-12-31) — Other Income Expense: 7694000.00
UVE cash_flow (annual, 2022-12-31) — Other Non Cash Items: -26051000.00
UVE balance_sheet (annual, 2022-12-31) — Other Payable: 18541000.00
UVE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 1014626000.00
UVE balance_sheet (annual, 2022-12-31) — Payables: 403045000.00
UVE balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 403045000.00
UVE income_statement (annual, 2022-12-31) — Policyholder Benefits Ceded: 1034142000.00
UVE income_statement (annual, 2022-12-31) — Policyholder Benefits Gross: 1972541000.00
UVE balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 10000.00
UVE balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
UVE cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -10000.00
UVE income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 10000.00
UVE balance_sheet (annual, 2022-12-31) — Prepaid Assets: 282427000.00
UVE income_statement (annual, 2022-12-31) — Pretax Income: -27247000.00
UVE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -276640000.00
UVE cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -6000.00
UVE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4899000.00
UVE balance_sheet (annual, 2022-12-31) — Receivables: 879952000.00
UVE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 7296000.00
UVE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1471000.00
UVE cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -11643000.00
UVE balance_sheet (annual, 2022-12-31) — Retained Earnings: 517455000.00
UVE cash_flow (annual, 2022-12-31) — Sale Of Investment: 132587000.00
UVE cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 0.00
UVE cash_flow (annual, 2022-12-31) — Sale Of PPE: 97000.00
UVE income_statement (annual, 2022-12-31) — Selling General And Administration: 90638000.00
UVE balance_sheet (annual, 2022-12-31) — Share Issued: 47179000.00
UVE cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4727000.00
UVE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 287896000.00
UVE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 287896000.00
UVE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (annual, 2022-12-31) — Tax Provision: -4990000.00
UVE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.18
UVE balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1528000.00
UVE balance_sheet (annual, 2022-12-31) — Total Assets: 2890154000.00
UVE balance_sheet (annual, 2022-12-31) — Total Capitalization: 390665000.00
UVE balance_sheet (annual, 2022-12-31) — Total Debt: 102769000.00
UVE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 287896000.00
UVE income_statement (annual, 2022-12-31) — Total Expenses: 1249905000.00
UVE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2602258000.00
UVE income_statement (annual, 2022-12-31) — Total Other Finance Cost: 703000.00
UVE balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
UVE balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 16790000.00
UVE balance_sheet (annual, 2022-12-31) — Treasury Stock: 238758000.00
UVE cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 13145000.00
UVE income_statement (annual, 2023-12-31) — +Total Revenue: 1391582000.00
UVE balance_sheet (annual, 2023-12-31) — Accounts Payable: 191850000.00
UVE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 296166000.00
UVE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 115086000.00
UVE cash_flow (annual, 2023-12-31) — Amortization Of Securities: 6563000.00
UVE income_statement (annual, 2023-12-31) — Basic Average Shares: 29829000.00
UVE income_statement (annual, 2023-12-31) — Basic EPS: 2.24
UVE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 391341000.00
UVE cash_flow (annual, 2023-12-31) — Capital Expenditure: -4019000.00
UVE balance_sheet (annual, 2023-12-31) — Capital Stock: 472000.00
UVE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 397306000.00
UVE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1461636000.00
UVE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -23289000.00
UVE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -47120000.00
UVE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -15251000.00
UVE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 70971000.00
UVE cash_flow (annual, 2023-12-31) — Change In Account Payable: -192654000.00
UVE cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 5886000.00
UVE cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -3000000.00
UVE cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 31465000.00
UVE cash_flow (annual, 2023-12-31) — Change In Payable: -184320000.00
UVE cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -184320000.00
UVE cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 46173000.00
UVE cash_flow (annual, 2023-12-31) — Change In Receivables: 583304000.00
UVE cash_flow (annual, 2023-12-31) — Change In Tax Payable: 5886000.00
UVE cash_flow (annual, 2023-12-31) — Change In Working Capital: -22313000.00
UVE cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 581756000.00
UVE cash_flow (annual, 2023-12-31) — Changes In Cash: 8600000.00
UVE balance_sheet (annual, 2023-12-31) — Common Stock: 472000.00
UVE cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -23279000.00
UVE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 341297000.00
UVE cash_flow (annual, 2023-12-31) — Common Stock Payments: -22021000.00
UVE balance_sheet (annual, 2023-12-31) — Current Debt: 14597000.00
UVE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 14597000.00
UVE cash_flow (annual, 2023-12-31) — Deferred Income Tax: 4409000.00
UVE cash_flow (annual, 2023-12-31) — Deferred Tax: 4409000.00
UVE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 7313000.00
UVE income_statement (annual, 2023-12-31) — Diluted Average Shares: 30147000.00
UVE income_statement (annual, 2023-12-31) — Diluted EPS: 2.22
UVE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 66813000.00
UVE income_statement (annual, 2023-12-31) — EBIT: 94172000.00
UVE cash_flow (annual, 2023-12-31) — End Cash Position: 399941000.00
UVE cash_flow (annual, 2023-12-31) — Excess Tax Benefit From Stock Based Compensation: -20000.00
UVE cash_flow (annual, 2023-12-31) — Financing Cash Flow: -47120000.00
UVE cash_flow (annual, 2023-12-31) — Free Cash Flow: 66952000.00
UVE cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 875000.00
UVE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 642000.00
UVE balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -74172000.00
UVE income_statement (annual, 2023-12-31) — General And Administrative Expense: 96055000.00
UVE cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 9702000.00
UVE balance_sheet (annual, 2023-12-31) — Income Tax Payable: 5886000.00
UVE income_statement (annual, 2023-12-31) — Interest Expense: 5823000.00
UVE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 5823000.00
UVE cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 5823000.00
UVE balance_sheet (annual, 2023-12-31) — Invested Capital: 443303000.00
UVE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -15251000.00
UVE balance_sheet (annual, 2023-12-31) — Investments And Advances: 1155259000.00
UVE balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 10434000.00
UVE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
UVE balance_sheet (annual, 2023-12-31) — Long Term Debt: 102006000.00
UVE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 102006000.00
UVE cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
UVE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1471000.00
UVE balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 10434000.00
UVE income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 992636000.00
UVE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -22021000.00
UVE income_statement (annual, 2023-12-31) — Net Income: 66823000.00
UVE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 66813000.00
UVE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 66823000.00
UVE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 66823000.00
UVE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 66823000.00
UVE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 66823000.00
UVE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 66823000.00
UVE income_statement (annual, 2023-12-31) — Net Interest Income: -6531000.00
UVE cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: 0.00
UVE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -11274000.00
UVE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -1471000.00
UVE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -1471000.00
UVE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -6531000.00
UVE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -339000.00
UVE balance_sheet (annual, 2023-12-31) — Net PPE: 47628000.00
UVE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -3977000.00
UVE income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 992636000.00
UVE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 341297000.00
UVE income_statement (annual, 2023-12-31) — Normalized Income: 66823000.00
UVE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 70971000.00
UVE cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1517000.00
UVE income_statement (annual, 2023-12-31) — Operating Revenue: 1391582000.00
UVE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 28966000.00
UVE balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 14597000.00
UVE balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -74172000.00
UVE income_statement (annual, 2023-12-31) — Other Gand A: 96055000.00
UVE income_statement (annual, 2023-12-31) — Other Income Expense: 7441000.00
UVE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 15101000.00
UVE balance_sheet (annual, 2023-12-31) — Other Payable: 35586000.00
UVE balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 1064330000.00
UVE balance_sheet (annual, 2023-12-31) — Payables: 233322000.00
UVE balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 233322000.00
UVE income_statement (annual, 2023-12-31) — Policyholder Benefits Ceded: 54218000.00
UVE income_statement (annual, 2023-12-31) — Policyholder Benefits Gross: 1046854000.00
UVE balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
UVE cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -10000.00
UVE income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 10000.00
UVE balance_sheet (annual, 2023-12-31) — Prepaid Assets: 236254000.00
UVE income_statement (annual, 2023-12-31) — Pretax Income: 88349000.00
UVE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -184673000.00
UVE cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: 0.00
UVE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -4019000.00
UVE balance_sheet (annual, 2023-12-31) — Receivables: 296166000.00
UVE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 7313000.00
UVE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1471000.00
UVE cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -22021000.00
UVE balance_sheet (annual, 2023-12-31) — Retained Earnings: 560690000.00
UVE cash_flow (annual, 2023-12-31) — Sale Of Investment: 173399000.00
UVE cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 0.00
UVE cash_flow (annual, 2023-12-31) — Sale Of PPE: 42000.00
UVE income_statement (annual, 2023-12-31) — Selling General And Administration: 96055000.00
UVE balance_sheet (annual, 2023-12-31) — Share Issued: 47269000.00
UVE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2916000.00
UVE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 341297000.00
UVE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 341297000.00
UVE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (annual, 2023-12-31) — Tax Provision: 21526000.00
UVE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.24
UVE balance_sheet (annual, 2023-12-31) — Taxes Receivable: 0.00
UVE balance_sheet (annual, 2023-12-31) — Total Assets: 2316561000.00
UVE balance_sheet (annual, 2023-12-31) — Total Capitalization: 443303000.00
UVE balance_sheet (annual, 2023-12-31) — Total Debt: 102006000.00
UVE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 341297000.00
UVE income_statement (annual, 2023-12-31) — Total Expenses: 1303233000.00
UVE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1975264000.00
UVE income_statement (annual, 2023-12-31) — Total Other Finance Cost: 708000.00
UVE balance_sheet (annual, 2023-12-31) — Total Tax Payable: 5886000.00
UVE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 18303000.00
UVE balance_sheet (annual, 2023-12-31) — Treasury Stock: 260779000.00
UVE cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -12046000.00
UVE income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 28438000.00
UVE income_statement (quarterly, 2024-09-30) — Other Gand A: 28438000.00
UVE income_statement (quarterly, 2024-09-30) — Selling General And Administration: 28438000.00
UVE balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 7480000.00
UVE income_statement (annual, 2024-12-31) — +Total Revenue: 1520536000.00
UVE balance_sheet (annual, 2024-12-31) — Accounts Payable: 220328000.00
UVE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 705553000.00
UVE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 121781000.00
UVE cash_flow (annual, 2024-12-31) — Amortization Of Securities: 3753000.00
UVE income_statement (annual, 2024-12-31) — Basic Average Shares: 28498000.00
UVE income_statement (annual, 2024-12-31) — Basic EPS: 2.07
UVE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 399941000.00
UVE cash_flow (annual, 2024-12-31) — Capital Expenditure: -7368000.00
UVE balance_sheet (annual, 2024-12-31) — Capital Stock: 475000.00
UVE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 259441000.00
UVE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1528520000.00
UVE cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -22326000.00
UVE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -47131000.00
UVE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -228092000.00
UVE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 137358000.00
UVE cash_flow (annual, 2024-12-31) — Change In Account Payable: 28478000.00
UVE cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -530000.00
UVE cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -8041000.00
UVE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -9086000.00
UVE cash_flow (annual, 2024-12-31) — Change In Payable: 32890000.00
UVE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 32890000.00
UVE cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -26462000.00
UVE cash_flow (annual, 2024-12-31) — Change In Receivables: -409948000.00
UVE cash_flow (annual, 2024-12-31) — Change In Tax Payable: -530000.00
UVE cash_flow (annual, 2024-12-31) — Change In Working Capital: 83214000.00
UVE cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -409948000.00
UVE cash_flow (annual, 2024-12-31) — Changes In Cash: -137865000.00
UVE balance_sheet (annual, 2024-12-31) — Common Stock: 475000.00
UVE cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -22316000.00
UVE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 373250000.00
UVE cash_flow (annual, 2024-12-31) — Common Stock Payments: -21914000.00
UVE cash_flow (annual, 2024-12-31) — Deferred Income Tax: -2570000.00
UVE cash_flow (annual, 2024-12-31) — Deferred Tax: -2570000.00
UVE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 6117000.00
UVE income_statement (annual, 2024-12-31) — Diluted Average Shares: 29274000.00
UVE income_statement (annual, 2024-12-31) — Diluted EPS: 2.01
UVE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 58918000.00
UVE income_statement (annual, 2024-12-31) — EBIT: 90379000.00
UVE cash_flow (annual, 2024-12-31) — End Cash Position: 262076000.00
UVE cash_flow (annual, 2024-12-31) — Excess Tax Benefit From Stock Based Compensation: 1205000.00
UVE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -47131000.00
UVE cash_flow (annual, 2024-12-31) — Free Cash Flow: 129990000.00
UVE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1767000.00
UVE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 104000.00
UVE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -63166000.00
UVE income_statement (annual, 2024-12-31) — General And Administrative Expense: 108639000.00
UVE income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 25856000.00
UVE cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 27570000.00
UVE balance_sheet (annual, 2024-12-31) — Income Tax Payable: 6561000.00
UVE income_statement (annual, 2024-12-31) — Interest Expense: 5768000.00
UVE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 5768000.00
UVE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 5768000.00
UVE balance_sheet (annual, 2024-12-31) — Invested Capital: 474493000.00
UVE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -228092000.00
UVE balance_sheet (annual, 2024-12-31) — Investments And Advances: 1362954000.00
UVE balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 16123000.00
UVE balance_sheet (annual, 2024-12-31) — Long Term Debt: 101243000.00
UVE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 101243000.00
UVE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1471000.00
UVE balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 16123000.00
UVE income_statement (annual, 2024-12-31) — Loss Adjustment Expense: 1087366000.00
UVE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -21914000.00
UVE income_statement (annual, 2024-12-31) — Net Income: 58928000.00
UVE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 58918000.00
UVE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 58928000.00
UVE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 58928000.00
UVE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 58928000.00
UVE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 58928000.00
UVE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 58928000.00
UVE income_statement (annual, 2024-12-31) — Net Interest Income: -6476000.00
UVE cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -2764000.00
UVE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -218068000.00
UVE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -1471000.00
UVE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -1471000.00
UVE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -6476000.00
UVE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1420000.00
UVE balance_sheet (annual, 2024-12-31) — Net PPE: 48653000.00
UVE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -7260000.00
UVE income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 1087366000.00
UVE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 373250000.00
UVE income_statement (annual, 2024-12-31) — Normalized Income: 58928000.00
UVE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 137358000.00
UVE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1871000.00
UVE income_statement (annual, 2024-12-31) — Operating Revenue: 1520536000.00
UVE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 28096000.00
UVE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -63166000.00
UVE income_statement (annual, 2024-12-31) — Other Gand A: 108639000.00
UVE income_statement (quarterly, 2024-12-31) — Other Gand A: 25856000.00
UVE income_statement (annual, 2024-12-31) — Other Income Expense: 8412000.00
UVE cash_flow (annual, 2024-12-31) — Other Non Cash Items: -14049000.00
UVE balance_sheet (annual, 2024-12-31) — Other Payable: 25931000.00
UVE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1269079000.00
UVE balance_sheet (annual, 2024-12-31) — Payables: 252820000.00
UVE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 252820000.00
UVE income_statement (annual, 2024-12-31) — Policyholder Benefits Ceded: 697767000.00
UVE income_statement (annual, 2024-12-31) — Policyholder Benefits Gross: 1785133000.00
UVE balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
UVE cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -10000.00
UVE income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 10000.00
UVE balance_sheet (annual, 2024-12-31) — Prepaid Assets: 262716000.00
UVE income_statement (annual, 2024-12-31) — Pretax Income: 84611000.00
UVE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -388132000.00
UVE cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -2764000.00
UVE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -7368000.00
UVE balance_sheet (annual, 2024-12-31) — Receivables: 705553000.00
UVE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 6117000.00
UVE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1471000.00
UVE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -21914000.00
UVE balance_sheet (annual, 2024-12-31) — Retained Earnings: 596853000.00
UVE cash_flow (annual, 2024-12-31) — Sale Of Investment: 170064000.00
UVE cash_flow (annual, 2024-12-31) — Sale Of PPE: 108000.00
UVE income_statement (annual, 2024-12-31) — Selling General And Administration: 108639000.00
UVE income_statement (quarterly, 2024-12-31) — Selling General And Administration: 25856000.00
UVE balance_sheet (annual, 2024-12-31) — Share Issued: 47478000.00
UVE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 8117000.00
UVE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 373250000.00
UVE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 373250000.00
UVE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (annual, 2024-12-31) — Tax Provision: 25683000.00
UVE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.30
UVE balance_sheet (annual, 2024-12-31) — Total Assets: 2841861000.00
UVE balance_sheet (annual, 2024-12-31) — Total Capitalization: 474493000.00
UVE balance_sheet (annual, 2024-12-31) — Total Debt: 101243000.00
UVE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 373250000.00
UVE income_statement (annual, 2024-12-31) — Total Expenses: 1435925000.00
UVE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2468611000.00
UVE income_statement (annual, 2024-12-31) — Total Other Finance Cost: 708000.00
UVE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 6561000.00
UVE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 19382000.00
UVE balance_sheet (annual, 2024-12-31) — Treasury Stock: 282693000.00
UVE cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -9936000.00
UVE income_statement (quarterly, 2025-03-31) — +Total Revenue: 394867000.00
UVE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 115136000.00
UVE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 543062000.00
UVE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 121875000.00
UVE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 28091000.00
UVE income_statement (quarterly, 2025-03-31) — Basic EPS: 1.48
UVE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 262076000.00
UVE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1227000.00
UVE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 476000.00
UVE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 398184000.00
UVE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 597346000.00
UVE cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -4844000.00
UVE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -6478000.00
UVE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -41548000.00
UVE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 138743000.00
UVE balance_sheet (quarterly, 2025-03-31) — Common Stock: 476000.00
UVE cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -4841000.00
UVE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 422387000.00
UVE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
UVE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 28779000.00
UVE income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.44
UVE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 41436000.00
UVE income_statement (quarterly, 2025-03-31) — EBIT: 56891000.00
UVE cash_flow (quarterly, 2025-03-31) — End Cash Position: 400819000.00
UVE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -6478000.00
UVE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 185542000.00
UVE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -51072000.00
UVE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 26670000.00
UVE balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 28567000.00
UVE income_statement (quarterly, 2025-03-31) — Interest Expense: 1435000.00
UVE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1435000.00
UVE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 523440000.00
UVE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -41548000.00
UVE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1420003000.00
UVE balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 15682000.00
UVE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 101053000.00
UVE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 101053000.00
UVE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -367000.00
UVE balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 15682000.00
UVE income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 250555000.00
UVE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
UVE income_statement (quarterly, 2025-03-31) — Net Income: 41439000.00
UVE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 41436000.00
UVE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 41439000.00
UVE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 41439000.00
UVE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 41439000.00
UVE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 41439000.00
UVE income_statement (quarterly, 2025-03-31) — Net Interest Income: -1612000.00
UVE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -40330000.00
UVE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -367000.00
UVE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -367000.00
UVE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1612000.00
UVE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1267000.00
UVE balance_sheet (quarterly, 2025-03-31) — Net PPE: 48258000.00
UVE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1218000.00
UVE income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 250555000.00
UVE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 422387000.00
UVE income_statement (quarterly, 2025-03-31) — Normalized Income: 41439000.00
UVE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 186769000.00
UVE income_statement (quarterly, 2025-03-31) — Operating Revenue: 394867000.00
UVE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 28190000.00
UVE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -51072000.00
UVE income_statement (quarterly, 2025-03-31) — Other Gand A: 26670000.00
UVE income_statement (quarterly, 2025-03-31) — Other Income Expense: 2322000.00
UVE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 26670000.00
UVE balance_sheet (quarterly, 2025-03-31) — Other Payable: 25752000.00
UVE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 199162000.00
UVE balance_sheet (quarterly, 2025-03-31) — Payables: 169455000.00
UVE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 169455000.00
UVE income_statement (quarterly, 2025-03-31) — Policyholder Benefits Ceded: -848000.00
UVE income_statement (quarterly, 2025-03-31) — Policyholder Benefits Gross: 249707000.00
UVE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
UVE cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -3000.00
UVE income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 3000.00
UVE balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 105480000.00
UVE income_statement (quarterly, 2025-03-31) — Pretax Income: 55456000.00
UVE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -77015000.00
UVE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1227000.00
UVE balance_sheet (quarterly, 2025-03-31) — Receivables: 543062000.00
UVE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -367000.00
UVE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
UVE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 633801000.00
UVE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 36685000.00
UVE cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 9000.00